ACUTE KIDNEY INJURY IN THE PATHOGENESIS OF CORONAVIRUS INFECTION


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

COVID-19 is an acute respiratory viral disease that primarily affects the lungs, but can also affect other organs, including the kidneys. Damage to the kidneys can be caused by direct effects arising from the invasion of the virus into kidney cells, or it occurs secondarily due to immunological, hemocoagulation and ischemic disorders. Given the importance of preserving kidney function during illness and after recovery, this review aims to investigate the impact of novel coronavirus infection on the kidney and its role in the development of acute kidney injury.

Толық мәтін

Рұқсат жабық

Авторлар туралы

V. Pavlov

FSBEI HE «Bashkir State Medical University» of the Ministry of Health of Russia

Email: pavlov@bashgmu.ru
Doctor of Medical Sciences, Professor, Corresponding Member of RAS, Rector, Head of the Urology Department Ufa, Russia

A. Tarasenko

FSAEI HE “First Moscow State Medical University named after I.M. Sechenov (Sechenov University) Ministry of Health of Russia

Email: tar-art@yandex.ru
Candidate of Medical Sciences, Deputy Director for Innovative Development Moscow, Russia

A. Papoyan

FSBEI HE «Bashkir State Medical University» of the Ministry of Health of Russia

Clinic Ufa, Russia

A. Alekseev

FSBEI HE «Bashkir State Medical University» of the Ministry of Health of Russia

Email: alekseevdlt@mail.ru
Candidate of Medical Sciences, Associate Professor of the Department of Urology with the course of IDPO Ufa, Russia

I. Kabirov

FSBEI HE «Bashkir State Medical University» of the Ministry of Health of Russia

Email: ildarkabirov@gmail.com
Candidate of Medical Sciences, Associate Professor of the Department of Urology, urologist of the urological department Ufa, Russia

Әдебиет тізімі

  1. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
  2. Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395: 507-513.
  3. Li Q., Guan X., Wu P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207.
  4. Wang L., Li X., Chen H., et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol 2020;51:343-348.
  5. Wang X., Fang X., Cai Z., et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Wash D C). 2020;2020:1-17.
  6. Yang A., Li H., Tao W., Yang X., et al. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients Aging (Albany NY). 2020 Jun 15; 12(11): 10059-10069.
  7. Hoffman M., Kleine-Weber H., Schroeder S., et al.: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e8.
  8. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-423.
  9. Martinez-Rojas M.A., Vega-Vega O., Bobadilla N.A. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020;318(6):F1454-F1462.
  10. Li Z., Wu M., Yao J., et al. Kidney dysfunctions of COVID-19 patients: a multi-centered, retrospective, observational study. Social Science Research Network, Rochester, N.Y.
  11. Hamming I., Timens W., Bulthuis M.L., et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-637.
  12. Pan X., Xu D., Zhang H. et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensiv Care Med. 2020;46,:1114- 1116.
  13. Kim J.M., Chung Y.S., Jo H.J., et al. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect. 2020;11:3-7.
  14. Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219-227.
  15. Ronco C., Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. April 2020.
  16. Naicker S., Yang C-W, Hwang S.-J., et al. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97:824-828.
  17. Vaduganathan M., Vardeny O., Michel T., et al. Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653-1659.
  18. Ronco C., Tetta C., Mariano F., et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27:792-801.
  19. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
  20. Desai T.R., Leeper N.J., Hynes K.L., Gewertz B.L. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118-123.
  21. Diao B., Wang C., Wang R., et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv 2020. https://doi.org/10.1101/2020.03.04.20031120
  22. Hua S., Ming Y., Cheng W., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020, [Epub ahead of print]:S0085-2538(20)30369-0.
  23. Kissling S., Rotman S., Gerber C., et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98:228-231.
  24. Lerolle N., Nochy D., Guérot E., et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensiv Care Med 2010;36:471-478.
  25. Cha R-H., Joh J-S., Jeong I., et al. Renal complications and their prognosis in Korean patients with middle East respiratory syndrome-coronavirus from the central MERS-CoV designated Hospital. J Korean Med Sci. 2015;30:1807-1814.
  26. Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. April 2020.
  27. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print Feb 7, 2020]. JAMA. Doi: 10.1001/ jama.2020.1585.
  28. Case J., Khan S., Khalid R., et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013;2013:479730.
  29. Chawla L.S., Eggers P.W., Star R.A., et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58-66.
  30. Murugan R., Kellum J.A. Acute kidney injury: what’s the prognosis? Nat Rev Nephrol. 2011;7:209-217.
  31. Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97: 829-838.
  32. Darmon M., Clec’h C., Adrie C., et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9:1347-1353.
  33. Wölfel R., Corman V.M., Guggemos W., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-469.
  34. Lo I., Lio C., Cheong H., Lei C., et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau Int J Biol Sci. 2020;16(10):1698-1707.
  35. Wang W., Xu Y., Gao R., et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens JAMA. 2020;323(18):1843-1844.
  36. Chan V., Chiu P., Yee C., et al. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions World J Urol. 2020;27:1-12.
  37. Kima J., Kima H., Leea J., Joa H., et al. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea Osong Public Health and Research Perspectives. 2020;11(3):112-117.
  38. Sun J., Li H., Zhuang Z., Chen Z. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Journal Emerging Microbes & Infections. 2020;9:991-993.
  39. Gaudry S., Hajage D., Schortgen F., et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122-133.
  40. Wu S., Liang X., Geng J., et al. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report. World J. Clin. Cases. 2019;7(24):4377-4383.
  41. Izzedine H., Jhaveri K.D., Perazella M.A. COVID-19 therapeutic options for patients with kidney disease. Kidney Int. 2020; 97(6):1297-129.
  42. Moore P.K., Hsu R.K., Liu K.D. Management of Acute Kidney Injury: Core Curriculum 2018. Am J Kidney Dis. 2018.;72(I.1):136-148.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2021